Search
for
Sort by
Research 601–630 of 1000+
- Prominent follicular mucinosis with diffuse scalp alopecia resembling alopecia areata
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Hypothyroidism in a Dog-A Case Report
- Unilateral nevoid hyperkeratosis of the nipple and areola in a Saudi female
- Serum androgen levels and their relationship to pattern and severity of hair growth in hirsute women presenting at private centre in Hyderabad
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Reply
- Platelet Immune Interactions, Lifespan, and Senescence
- Iraqi Women with Hirsutism, Clinical and Biochemical Characteristics: Retrospective Study
- Efficacy and safety of diode laser for facial hair reduction in hirsutism—a clinico-trichoscopic evaluation
- Role of Lactoferrin in Chronic Telgon Effluvium
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- The lowest effective dose of botulinum toxin in detrusor sphincter dyssynergia
- SUMMARIES OF PAPERS
- Effectiveness and safety of triple-diode laser with or without adjunctive topical eflornithine in female hirsutism
- Generalised Gingival Fibromatosis and Hypertrichosis: A Rare Case of Syndromic Presentation
- Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism
- Update: baricitinib for alopecia areata
- Management of women with hirsutism in Kosovo
- The prevalence of thyroid function test abnormalities and serum thyroid autoantibodies in vitiligo and alopecia areata patients in Saudi Arabian population
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Management of Hirsutism Associated With Obese PCOD - A Case Report
- A review on follicular targeting for the treatment of hirsutism
- Folliculotropic mycosis fungoides
- Anxiety and Hair Restoration Surgery
- Issue Information
- The eyelash comes to the fore
- Pramipexole
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- 13. Wound Healing & Hair